Professional Experience
Raymond R. Mandra is the Chair of the firm's Biotechnology Practice Group.
He joined Fitzpatrick, Cella, Harper & Scinto in 1989. Since that time he has concentrated in the areas of patent counseling, contentious proceedings before the United States Patent and Trademark Office, application writing, prosecution, litigation, licensing and due diligence primarily involving the chemical, food, pharmaceutical and biotechnological sciences.
Mr. Mandra has prepared numerous chemical, pharmaceutical and food related patent applications and patents for various clients, including Astellas Pharma Inc., Bristol-Myers Squibb, Genzyme, Leo Pharma Inc., Mars Incorporated, Novartis, Pfizer, Sanofi and Warner Chilcott. Mr. Mandra has extensive experience in the prosecution of both U.S. patent applications and international patent applications under the Patent Cooperation Treaty. He has also been substantially involved in various patent litigations, reexaminations, interferences and reissues.
Prior to joining Fitzpatrick, Cella, Harper & Scinto, Mr. Mandra worked for nine years as a chemist for the General Foods Corporation.
Awards and Recognition
Mr. Mandra was listed in Legal 500 2007, 2008, 2009 and 2010 in Patent Litigation. He was also listed as a Leading Lawyer in Legal 500 2008 for Patent Re-examination and in Legal 500 2010 and 2011 for Patent prosecution: utility and design. Mr. Mandra was selected by Patent Buddy as one of the Top Patent Prosecutors nationally in the Pharmaceutical Biotechnology area for 2011 and was the recipient of the 2012 ILO Client Choice Individual Award for Intellectual Property in the United States.
Professional Activities
American Bar Association; American Intellectual Property Law Association; New York Intellectual Property Law Association
Publications/Events
Publications
Innovator versus Generic
European Pharmaceutical Contractor
June 2011
Supporting Patentability With Commercial Success
Law 360
September 24, 2009
Stem Cells and Patenting and Related Regulatory Issues: A United States Perspective
Bio-Science Law Review
September/October 2005
Events
ACI's 2nd Annual Conference on Biosimilars
American Conference Institute
Fitzpatrick partners Raymond Mandra and Ha Kung Wong spoke at ACI's 2nd Annual Conference on Biosimilars
June 7-8, 2011
Follow-on Biologics Legislation and the U.S. Healthcare Reforms
Biotech Patent Conference
Raymond Mandra spoke on Biologics Legislation and the U.S. Healthcare Reforms
March 17, 2011
Supplementing PTE Through the Use of Second Generation Patents
American Conference Institute
Raymond Mandra spoke on Patent Term Extensions
January 27, 2011
12th Advanced Forum on Biotech Patents Conference
American Conference Institute
Partner Raymond Mandra spoke at ACI's 12th Advanced Forum on Biotech Patents Conference.
November 30 - December 1, 2010
Follow On Biologics Conference
American Conference Institute
Partners Raymond Mandra and Leisa Smith Lundy presented at ACI's Follow On Biologics Conference on June 21st.
June 21-22, 2010
18th Annual C5 Forum on Biotech Patenting
C5
March 17-19, 2010
5th Annual Developing IP Strategies for Crystalline Forms Conference
IQPC
November 9-11, 2009
Highlighting In-Depth Interference Practices, Patent Life Cycle Management and Litigation Tactics
IQPC's 2nd Annual Patent Strategies for the Pharma, Biotech and Medical Device Industries
July 15-16, 2008
Best Practices for Evaluating Your Infringement Risk and Interpreting the Claims
C5's 5th Annual International Freedom to Operate Forum
June 10, 2008
Eyes Wide Open: What You Must Do to See Beyond the Veil (FTO in the Wider Context)
C5 4th International FTO Forum
March 29, 2007
Due Diligence Required Prior to Licensing a Pharmaceutical Candidate
C5 BioPharm Licensing Conference
December 6, 2006
Recent Reforms in PCT Practice
New York Intellectual Property Law Association Fall CLE Program
November 21, 2003
Compliance with the Written Description Requirement
AIPLA's Advanced Patent Prosecution Training Seminar
June 12, 2003
Claim Construction, Anticipation and Section 112 Issues
NYIPLA CLE Luncheon
March 28, 2003